Intuitive Surgical, Inc. $ISRG Stock Holdings Lifted by Ewa LLC

Ewa LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.9% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 667 shares of the medical equipment provider’s stock after buying an additional 49 shares during the quarter. Ewa LLC’s holdings in Intuitive Surgical were worth $362,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Aaron Wealth Advisors LLC grew its position in Intuitive Surgical by 0.8% in the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after acquiring an additional 19 shares during the last quarter. Crown Wealth Group LLC boosted its stake in shares of Intuitive Surgical by 4.8% during the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock valued at $218,000 after purchasing an additional 20 shares in the last quarter. FSM Wealth Advisors LLC lifted its stake in shares of Intuitive Surgical by 3.8% in the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock worth $270,000 after acquiring an additional 20 shares during the period. CFO4Life Group LLC lifted its stake in shares of Intuitive Surgical by 4.8% in the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock worth $216,000 after acquiring an additional 20 shares during the period. Finally, J. W. Coons Advisors LLC lifted its stake in shares of Intuitive Surgical by 1.4% in the first quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock worth $741,000 after acquiring an additional 20 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on ISRG shares. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. The Goldman Sachs Group decreased their price target on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a report on Wednesday. UBS Group upped their price target on Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a report on Wednesday, July 23rd. Wells Fargo & Company boosted their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 23rd. Finally, Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $594.19.

Intuitive Surgical Trading Down 2.1%

Shares of Intuitive Surgical stock opened at $438.04 on Thursday. The firm has a market capitalization of $157.03 billion, a PE ratio of 61.09, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61. The business’s 50-day moving average price is $465.33 and its 200-day moving average price is $500.54. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same period in the prior year, the company earned $1.78 EPS. The company’s revenue was up 21.4% on a year-over-year basis. As a group, analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the sale, the director directly owned 739 shares in the company, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.